Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients

20 Oct 2023

Abstract excerpt

A growing number of druggable targets and national initiatives for precision oncology necessitate broad genomic profiling for many cancer patients. Whole exome sequencing (WES) offers unbiased analysis of the entire coding sequence, segmentation-based detection of copy number alterations (CNAs), and accurate determination of complex biomarkers including tumor mutational burden (TMB), homologous recombination...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Genetic factors in colorectal cancer
Share to Genomics and Rare Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37864096
DOI: 10.1038/s41698-023-00457-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patientsPMID 37864096Read ↗

Benchmarking whole exome sequencing in the German network for personalized medicineSemantic proximity Read ↗

An absolute approach to using whole exome DNA and RNA workflow for cancer biomarker testingSemantic proximity Read ↗

Multicenter In-House Evaluation of an Amplicon-Based Next-Generation Sequencing Panel for Comprehensive Molecular Profiling.Semantic proximity Read ↗

Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer careSemantic proximity Read ↗

Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicineSemantic proximity Read ↗

Technical validation of a fully integrated NGS platform in real-world practice of Italian referral institutionSemantic proximity Read ↗

Validation and Implementation of a Somatic-Only Tumor Exome for Routine Clinical Application.Semantic proximity Read ↗

A comparative assessment of clinical whole exome and transcriptome profiling across sequencing centers: implications for precision cancer medicine.Semantic proximity Read ↗

Institutional implementation of clinical tumor profiling on an unselected cancer population.Semantic proximity Read ↗

Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing.Semantic proximity Read ↗

Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines.Semantic proximity Read ↗

Whole Genome and Exome Sequencing Reference Datasets from A Multi-center and Cross-platform Benchmark StudySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.